
<document id="DBMI.pac122" origId="pac122">
	<sentence id="DBMI.pac122.s0" origId="s0" text="7 DRUG INTERACTIONS\n\n7.1 CYP2C8 Inhibitors and Inducers\n\nAn inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.">
		<entity charOffset="170-179" id="DBMI.pac122.s0.e0" origId="s0.e0" text="rifampin " type="Active ingredient"/>
		<entity charOffset="204-218" id="DBMI.pac122.s0.e1" origId="s0.e1" text="rosiglitazone " type="Active ingredient"/>
		<entity charOffset="87-99" id="DBMI.pac122.s0.e2" origId="s0.e2" text="gemfibrozil " type="Active ingredient"/>
		<pair e1="DBMI.pac122.s0.e0" e2="DBMI.pac122.s0.e1" id="DBMI.pac122.s0.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="rosiglitazone " precipitant="rifampin "/>
		<pair e1="DBMI.pac122.s0.e0" e2="DBMI.pac122.s0.e2" id="DBMI.pac122.s0.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.s0.e1" e2="DBMI.pac122.s0.e0" id="DBMI.pac122.s0.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.s0.e1" e2="DBMI.pac122.s0.e2" id="DBMI.pac122.s0.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.s0.e2" e2="DBMI.pac122.s0.e0" id="DBMI.pac122.s0.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.s0.e2" e2="DBMI.pac122.s0.e1" id="DBMI.pac122.s0.p5" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="rosiglitazone " precipitant="gemfibrozil "/>
	</sentence>
	<sentence id="DBMI.pac122.s1" origId="s1" text="Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response."/>
	<sentence id="DBMI.pac122.s2" origId="s2" text="[See Clinical Pharmacology (12.4).]"/>
	<sentencespan id="DBMI.pac122.sp0" origId="sp0" text="7 DRUG INTERACTIONS\n\n7.1 CYP2C8 Inhibitors and Inducers\n\nAn inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).]">
		<entity charOffset="170-179" id="DBMI.pac122.sp0.e0" origId="sp0.e0" text="rifampin " type="Active ingredient"/>
		<entity charOffset="204-218" id="DBMI.pac122.sp0.e1" origId="sp0.e1" text="rosiglitazone " type="Active ingredient"/>
		<entity charOffset="87-99" id="DBMI.pac122.sp0.e2" origId="sp0.e2" text="gemfibrozil " type="Active ingredient"/>
		<pair e1="DBMI.pac122.sp0.e0" e2="DBMI.pac122.sp0.e1" id="DBMI.pac122.sp0.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="rosiglitazone " precipitant="rifampin "/>
		<pair e1="DBMI.pac122.sp0.e0" e2="DBMI.pac122.sp0.e2" id="DBMI.pac122.sp0.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.sp0.e1" e2="DBMI.pac122.sp0.e0" id="DBMI.pac122.sp0.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.sp0.e1" e2="DBMI.pac122.sp0.e2" id="DBMI.pac122.sp0.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.sp0.e2" e2="DBMI.pac122.sp0.e0" id="DBMI.pac122.sp0.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac122.sp0.e2" e2="DBMI.pac122.sp0.e1" id="DBMI.pac122.sp0.p5" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="rosiglitazone " precipitant="gemfibrozil "/>
	</sentencespan>
</document>
